ANGO logo

ANGO
Angiodynamic Inc

1,062
Mkt Cap
$468.64M
Volume
850,153.00
52W High
$13.99
52W Low
$8.36
PE Ratio
-17.74
ANGO Fundamentals
Price
$11.94
Prev Close
$11.37
Open
$11.43
50D MA
$10.85
Beta
1.07
Avg. Volume
369,931.51
EPS (Annual)
-$0.8321
P/B
2.82
Rev/Employee
$433,330.37
$364.75
Loading...
Loading...
News
all
press releases
AngioDynamics (NASDAQ:ANGO) Downgraded to Hold Rating by Zacks Research
Zacks Research downgraded AngioDynamics from a "strong-buy" rating to a "hold" rating in a research report on Monday...
MarketBeat·22h ago
News Placeholder
More News
News Placeholder
AngioDynamics to Present at the 25th Annual Needham Virtual Healthcare Conference
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the bodys vascular system, expanding cancer treatment options...
Business Wire·2d ago
News Placeholder
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Decreases By 18.0%
AngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) was the target of a significant decline in short interest in March. As of March 13th, there was short interest totaling 1,784,550 shares, a decline...
MarketBeat·3d ago
News Placeholder
AngioDynamics, Inc. (NASDAQ:ANGO) Receives Average Recommendation of "Moderate Buy" from Brokerages
AngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) has earned a consensus rating of "Moderate Buy" from the five brokerages that are covering the company, Marketbeat Ratings reports. One equities...
MarketBeat·4d ago
News Placeholder
AngioDynamics (ANGO) Expected to Announce Quarterly Earnings on Thursday
AngioDynamics (NASDAQ:ANGO) will be releasing its Q3 2026 earnings before the market opens on Thursday, April 2. (View Earnings Report at...
MarketBeat·7d ago
News Placeholder
AngioDynamics to Report Fiscal 2026 Third Quarter Results on April 2, 2026
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the bodys vascular system, expanding cancer treatment options...
Business Wire·14d ago
News Placeholder
InspireMD, Inc. (NSPR) Reports Q4 Loss, Beats Revenue Estimates
InspireMD (NSPR) delivered earnings and revenue surprises of +36.36% and +14.93%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·15d ago
News Placeholder
AngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Update
AngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) was the target of a significant increase in short interest during the month of February. As of February 27th, there was short interest totaling...
MarketBeat·18d ago
News Placeholder
Reasons to Add AngioDynamics Stock to Your Portfolio for Now
ANGO stock is buoyed by strong fiscal Q2 results, surging NanoKnife adoption in prostate cancer and broad Med Tech growth supporting margins.
Zacks·22d ago
News Placeholder
AngioDynamics CEO Details Portfolio Shift as Auryon, AlphaVac and NanoKnife Fuel Growth at Conference
AngioDynamics (NASDAQ:ANGO) CEO Jim Clemmer said the company has spent the last several years reshaping its portfolio and operating model, moving away from slower-growth, more commodity-oriented...
MarketBeat·23d ago
<
1
2
...
>

Latest ANGO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.